Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Osborn

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Stem Cells and Development|May 14, 2019
Hematotherapy: Pioneers and PathfindersMark J Osborn
Translational Research : the Journal of Laboratory and Clinical Medicine|June 16, 2015
Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosaChristopher Perdoni, Mark J Osborn, Jakub Tolar
Cytotherapy|September 23, 2021
Differentiation of immortalized human multi-lineage progenitor to alveolar type 2-like cells: angiotensin-converting enzyme 2 expression and binding of severe acute respiratory syndrome coronavirus 2 spike and spike 1 proteinsDaniel P Collins, Mark J Osborn, Clifford J Steer
International Journal of Hematology|May 29, 2016
Gene editing and its application for hematological diseasesMark J Osborn, Joseph J Belanto, Jakub Tolar, et al.
Human Gene Therapy|June 14, 2011
Synthetic zinc finger nuclease design and rapid assemblyMark J Osborn, Anthony P DeFeo, Bruce R Blazar, et al.
International Journal of Molecular Sciences|January 25, 2018
Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-TDok Hyun Yoon, Mark J Osborn, Jakub Tolar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2025
Progress in skin gene therapy: From the inside and outMark J Osborn, Sidharth Panda, Theresa M Reineke, et al.
Biomedicines|January 21, 2022
Revertant Mosaicism in Epidermolysis BullosaCameron Meyer-Mueller, Mark J Osborn, Jakub Tolar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2008
Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene productMark J Osborn, Ron T McElmurry, Brandon Peacock, et al.
Pediatric Research|March 30, 2018
Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosaMichael Vanden Oever, Kirk Twaroski, Mark J Osborn, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Stem Cells and Development|May 14, 2019
Hematotherapy: Pioneers and PathfindersMark J Osborn
Translational Research : the Journal of Laboratory and Clinical Medicine|June 16, 2015
Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosaChristopher Perdoni, Mark J Osborn, Jakub Tolar
Cytotherapy|September 23, 2021
Differentiation of immortalized human multi-lineage progenitor to alveolar type 2-like cells: angiotensin-converting enzyme 2 expression and binding of severe acute respiratory syndrome coronavirus 2 spike and spike 1 proteinsDaniel P Collins, Mark J Osborn, Clifford J Steer
International Journal of Hematology|May 29, 2016
Gene editing and its application for hematological diseasesMark J Osborn, Joseph J Belanto, Jakub Tolar, et al.
Human Gene Therapy|June 14, 2011
Synthetic zinc finger nuclease design and rapid assemblyMark J Osborn, Anthony P DeFeo, Bruce R Blazar, et al.
International Journal of Molecular Sciences|January 25, 2018
Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-TDok Hyun Yoon, Mark J Osborn, Jakub Tolar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2025
Progress in skin gene therapy: From the inside and outMark J Osborn, Sidharth Panda, Theresa M Reineke, et al.
Biomedicines|January 21, 2022
Revertant Mosaicism in Epidermolysis BullosaCameron Meyer-Mueller, Mark J Osborn, Jakub Tolar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2008
Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene productMark J Osborn, Ron T McElmurry, Brandon Peacock, et al.
Pediatric Research|March 30, 2018
Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosaMichael Vanden Oever, Kirk Twaroski, Mark J Osborn, et al.
Pageof 7